NZ179623A - Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund - Google Patents

Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund

Info

Publication number
NZ179623A
NZ179623A NZ179623A NZ17962375A NZ179623A NZ 179623 A NZ179623 A NZ 179623A NZ 179623 A NZ179623 A NZ 179623A NZ 17962375 A NZ17962375 A NZ 17962375A NZ 179623 A NZ179623 A NZ 179623A
Authority
NZ
New Zealand
Prior art keywords
receptor blocking
compound
compund
beta
alpha
Prior art date
Application number
NZ179623A
Other languages
English (en)
Inventor
P Imhof
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of NZ179623A publication Critical patent/NZ179623A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/625Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ179623A 1975-01-06 1975-12-22 Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund NZ179623A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7175 1975-01-06

Publications (1)

Publication Number Publication Date
NZ179623A true NZ179623A (en) 1978-03-06

Family

ID=4178628

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ179623A NZ179623A (en) 1975-01-06 1975-12-22 Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund

Country Status (14)

Country Link
JP (1) JPS5191337A (fr)
AU (1) AU499140B2 (fr)
BE (1) BE837293A (fr)
CA (1) CA1063516A (fr)
DE (1) DE2600069A1 (fr)
FR (1) FR2296430A1 (fr)
GB (1) GB1510370A (fr)
HK (1) HK49680A (fr)
IE (1) IE42766B1 (fr)
IL (1) IL48785A (fr)
MY (1) MY8100159A (fr)
NL (1) NL7600045A (fr)
NZ (1) NZ179623A (fr)
ZA (2) ZA7628B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019006A1 (fr) * 1979-05-14 1980-11-26 Ciba-Geigy Ag Préparations pharmaceutiques contenant un dérivé substitué de pyrazolidine comme substance active, leur application et procédé pour leur fabrication
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
TW284688B (fr) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL37700A (en) * 1970-10-02 1975-05-22 Ciba Geigy Ag Pharmaceutical preparations containing an aryloxypropanolamine derivative or an arylethanolamine derivative

Also Published As

Publication number Publication date
BE837293A (fr) 1976-07-05
CA1063516A (fr) 1979-10-02
IE42766L (en) 1976-07-06
IL48785A0 (en) 1976-03-31
GB1510370A (en) 1978-05-10
MY8100159A (en) 1981-12-31
NL7600045A (nl) 1976-07-08
ZA7628B (en) 1976-12-29
AU499140B2 (en) 1979-04-05
FR2296430A1 (fr) 1976-07-30
IL48785A (en) 1978-08-31
IE42766B1 (en) 1980-10-08
ZA7626B (en) 1976-12-29
JPS5191337A (fr) 1976-08-10
FR2296430B1 (fr) 1978-11-10
HK49680A (en) 1980-09-12
AU1000276A (en) 1977-07-14
DE2600069A1 (de) 1976-07-15

Similar Documents

Publication Publication Date Title
JPS5242590A (en) Powder copolymers
PT65863A (en) Capsules
AU2223177A (en) Inhilator for powdered medicaments
ZA765028B (en) Photothermographic toners
JPS5218792A (en) Copolymers containing hydrazide succinate units
AU2510477A (en) A radiation sensitive record
DE2861748D1 (en) Stilbene derivatives, their preparation and medicines containing these stilbene derivatives
GB1557887A (en) Pressure sensitive recording systems
AU512862B2 (en) Collimator for scintillation camera
JPS5252762A (en) Blocking element
JPS5230339A (en) Data detector
HU175861B (hu) Predokhranjajuhhaja blokirovki sistema regulirovanija
JPS539189A (en) Slide powder device
AU1085976A (en) Xray detector
JPS55129340A (en) Radiation sensitive elements
NZ179623A (en) Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund
AU505377B2 (en) Dropout detector
JPS5421100A (en) Explosive powder case
JPS51114103A (en) Tape feeder
IL53452A0 (en) A new combination of drugs for the selective control of immune reactions
JPS5292697A (en) Tape tightening mechanism for packer
JPS5280238A (en) Preetreatment for powder application
JPS5270786A (en) Device for opening radiation photograph cassette at daylight
JPS5328346A (en) Address setting error detector
AU502971B2 (en) Capsules for securing elements ina borehole